← Eichor
Condition: Elevated Lp A Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Elevated Lp A

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · 249 location(s) · Amgen · NCT07136012Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
Phase N/A · 1 location(s) · University of Galway · NCT07577609Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · 40 location(s) · Amgen · NCT07293260Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · 772 location(s) · Eli Lilly and Company · NCT07157774Pelacarsen Roll-over Extension Program
Phase 3 · 97 location(s) · Novartis Pharmaceuticals · NCT06875973Lipid Screening Study
Phase N/A · 1 location(s) · University of Central Florida · NCT07579325Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Gliobl
Phase 1 · 2 location(s) · University of Florida · NCT04573140A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
Phase 1/Phase 2 · 1 location(s) · Sirius Therapeutics Co., Ltd. · NCT07172646Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Phase 2 · 59 location(s) · Kylonova (Xiamen) Biopharma co., LTD. · NCT0732784024 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06014060RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Phase 1 · 1 location(s) · University of Florida · NCT07492316A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Ev
Phase 3 · 58 location(s) · Eli Lilly and Company · NCT07613294A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Phase 2 · 12 location(s) · Merck Sharp & Dohme LLC · NCT07614984
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.